Anti-Firefly Luciferase antibody [EPR17790],Abcam,AB185924

Anti-Firefly Luciferase antibody [EPR17790] (ab185924) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, ICC/IF, WB in firefly samples. Anti-Firefly Luciferase antibody [EPR17790] (ab185924) has been cited over 18 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-Firefly Luciferase antibody [EPR17790] (ab185924) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Firefly Luciferase antibody [EPR17790] (ab185924) specifically detects Firefly Luciferase (UniProt ID: P08659; Molecular weight: 61kDa) and is sold in 100 uL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR17790 - ab232629 . Antibody clone EPR17790 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647 ( ab21495 , ab23349). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .